Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study — Arnaud Jaccard (2024) | RDL Network
Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study
A. Jaccard, Frank Bridoux, Wilfried Roeloffzen, Monique C. Minnema, Rui Bergantim, Roman Hájek, C. João, María Teresa Cibeira, Giovanni Palladini, Stefan Schönland, Giampaolo Merlini, Pamela Milani, Meletios A Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Hermine Agis, B. Gros, A Asra, Eileen Dergarabetian, V. Magarotto, A. Leonidakis, G. Cheliotis, Pieter Sonneveld, AD Wechalekar,
SN Willich, Ling‐Hsiang Chuang, Ben van Hout, Giancarlo Agnelli, PD Gumbs, Rupert Bauersachs, Patrick Mismetti, David Jiménez, A. K. Gitt, Sonja Kroep, M. Monreal, AT Cohen
Discussion(0)
No comments yet. Be the first to comment.